As demands on trade secret teams grow, relying on integrated IP protection systems, such as DLPs, becomes ever more important. This roundtable focuses on the real-world application of these tools.
Agriculture is often framed as part of the climate problem—but it also holds untapped potential as a scalable carbon removal solution. This session explores how regenerative practices, when paired with robust measurement and market infrastructure, can transform working lands into reliable carbon sinks. We’ll unpack what it takes to move from practice-based claims to verified outcomes, and how companies, farmers, and policymakers can align to unlock agriculture’s role as a true removal engine.

Catherine Coteus
Brings over a decade of experience in corporate carbon accounting and decarbonization strategy, with expertise spanning sustainable agriculture, net-zero pathways, climate risk, and corporate climate programs. Advised many global companies on climate strategy.

Catherine Coteus
Brings over a decade of experience in corporate carbon accounting and decarbonization strategy, with expertise spanning sustainable agriculture, net-zero pathways, climate risk, and corporate climate programs. Advised many global companies on climate strategy.
Employee movement is the most common trigger for trade secret disputes. This roundtable explores how companies balance protection, culture, and retention in high-mobility environments.

Barry Golob
As manufacturing, R&D, and services become increasingly outsourced, companies face heightened leakage risk outside their four walls. This roundtable examines how in-house teams protect trade secrets across complex vendor networks.
Trade secret cases are often won or lost on contemporaneous evidence. This roundtable focuses on how companies build defensible records before any misappropriation is suspected.

Barbara Fiacco
Mergers and acquisition bring about profound risk for the loss or theft of proprietary information, with he added complications of uncatalogued trade secrets and departing employees with deep process knowledge only increasing these risks. This session will discuss practical strategies that in-house teams are implementing to mitigate these risks and allow for smooth M&A proceedings.
- Integration of M&A systems to prevent risk during acquisition, and balance restrictive covenants.
- How to mitigate the risk posed by departing employees with deep process knowledge.
- Balancing enforcement with workforce mobility and ensuring that morale and professionality is maintained.
- Strategies for joint development M&A.

Lana Gladstein
Lana Gladstein currently works as a General Counsel for Seaport Therapeutics. She previously worked at APRINOIA Therapeutics as a Group General Counsel. Lana Gladstein attended Northeastern University School of Law.

Jim Gale
Beyond legal risk, trade secret disputes can result in catastrophic knock-on effects throughout a business: they can disrupt operations, drain technical teams, and affect investor confidence for years. This fireside chat looks at how in-house teams manage trade secret litigation when the stakes extend far beyond the courtroom.
- How litigation strategy changes when trade secret disputes become ‘bet-the-business’ matters.
- Managing discovery scope, technical witness fatigue, and internal disruption over multi-year disputes.
- Navigating investor relations, disclosure obligations, and activist pressure during ongoing litigation.
- Decision-making around settlement, arbitration, or escalation when business survival is at stake.

Brian Walters
Brian D. Walters serves as Executive Vice-President and General Counsel for Matthews International Corporation, Pittsburgh’s oldest company in continuous operation since 1850 and operating in over 25 countries with over 12,000 employees. During his 18-year tenure at Matthews, the Company has more than tripled in annual revenue, now producing approximately $1.8 billion in sales. Brian has directed all legal matters for this publicly-traded corporation both nationally and internationally, as well as serving as a member of Matthews’ executive leadership team. Mr. Walters has led over 75 domestic and foreign acquisition initiatives at Matthews, including extensive experience coordinating strategies to secure transaction approval from the U.S. Federal Trade Commission, managing HSR filings, as well as filings with the competition authority of the European Union.

Rob Rodrigues

Sheryl Garko
Strategic collaborations are increasingly central to innovation, particularly in life sciences and technology, where companies rely on partnerships for research, development, and manufacturing. This session explores the trade secret considerations that arise across the full lifecycle of a collaboration, from early discussions and deal negotiation to active partnerships and potential disputes.
- Trade secret strategy during early deal exploration and negotiating terms that protect the ownership of know-how, confidentiality obligations, and information access.
- Offensive and defensive considerations when collaborations lead to litigation or misappropriation claims.
- Managing trade secrets during active collaborations such as joint R&D, licensing, or manufacturing partnerships.
- Trade secret risks when collaborations fail, including “busted deals,” employee mobility, and disputes over the use of shared know-how.


